Skip Navigation Links
Company Intelligence: Evonik Industries

Evonik Industries | Company Structure Information from ICIS

 

Evonik Industries is formally known as Degussa, a wholly owned subsidiary of the RAG group, and is a specialty chemical company. It claims to be the third largest chemical company in Germany, the world's seventh largest chemical company and the world's number one in speciality chemicals. Evonik Industries Headquarters (Source: Evonik Industries)

 

In 2008, Evonik Industries had a workforce of around 40,767, generated sales of Euro16bn and had customers in more than 100 countries.

 

History

 

On 9 February 2001, two global producers, Degussa-Huls and SKW, came together and formed the new Degussa AG. In March 2001, Laporte, a UK-based fine and performance chemicals company, joined Degussa to form one of the world's leading major speciality chemical companies.

 

On 12 September 2007, Degussa was renamed Evonik Chemicals and is part of Evonik Industries.

 

Company movements

 

In October 2009, Evonik sold its specialty chemicals unit AlzChem to BluO. For more on this please see Germany's Evonik sells AlzChem Group to BluO for €78.5m on ICIS news. The deal was first announced in September 2009.

 

Also in October 2009, Evonik agreed to acquire Eli Lilly’s Tippecanoe Laboratories manufacturing facility in Lafayette, Indiana. For more on this story please see Evonik expands US synthesis business with Eli Lilly acquisition on ICIS news.

 

Please see Evonik, Cristal Material form glass lenses venture for LEDs on ICIS news

 

In November 2008, Evonik sold its Seal Sands, UK, fine organics business to local management. Financial terms of the deal were not disclosed. The management buyout team have established a new company, Fine Organics Limited.

 

Evonik’s owner RAG sold a 25.01% stake in the company to private equity firm Capital Partners (CVC) for €2.4bn. RAG also said that it plans to float the company by 2013.

 

An Evonik IPO had previously been planned for 2008.

 

In July 2008, Evonik Industries closed the sale of the Initiators group to the US investor Speyside Equity for an undisclosed purchase price. Following approval by relevant bodies and antitrust authorities, the transaction was closed on 30 June 2008.

 

In May 2008, Evonik Industries completed the sale of its coal tar chemicals firm Rutgers Chemicals to private equity investor Triton for an undisclosed sum. Evonik decided to divest Rutgers as part of its strategy to focus its chemicals business area on specialty chemicals.

 

Evonik is separated into three segments: Chemicals, Energy and Real Estate.

 

Chemicals

 

Technology Specialities

 

This division comprises of business units that are based on special technologies, such as synthetic building blocks for the pharmaceuticals industry and biodiesel catalysts.

 

The business unit consists of:

 

Industrial chemicals

Inorganic materials

 

Consumer Solutions

 

The Consumer Solutions business units include:

 

Consumer specialties

Health and Nutrition

 

Specialty Materials

 

The Specialty Materials segment comprises of high-performance material businesses. Many of the products are manufactured from methyl methacrylate (MMA). The business units include:

 

Coatings and additives 

Performance Polymers 

 

Energy 

 

Energy

 

Real Estate

 

Real Estate

Evonik Industries Strategy & Financial Highlights

Evonik states that it has a clear ongoing strategy. It is concentrating on achieving ambitious growth and profitability targets. Its goal is not “simply to be a specialty chemicals company, but to rank among the best”. That it says is the purpose of the “Evonik 2008” strategy programme. (Edited from: company website). ICIS also provides you with key financial data listed in table form. More about Evonik Industries Strategy & Financial Highlights

News:

Get news on Evonik Industries plus the latest chemical news, information, data, market movements and analysis in one place with ICIS news

Search:

Find details on other chemical companies and suppliers with ICIS search

Newsletters:

ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.

Plants and projects:

Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database

 
Free trial to ICIS
ICIS Chemical Business - ICIS Chemical Business Endpoint
This blog records content for the Endpoint page of ICIS Chemical Business ahead of publication. It is a series of works in progress. To read the definitive version of the column subscribe to ICIS Chemical Business on paper and on line

Insight

INSIGHT: Industry needs to maintain LRI momentum
“The decision to reduce overall spending on LRI is not a positive move. The industry is still a long way from allaying many of the concerns that beset more

VIDEO - ICIS news Europe Lunchtime Bulletin 25 November 2009

More...

We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.